GlassScriptPhysician profile
Grayson J Guzman
NPI 1417028218
$3,703.56
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,865 · 2020: $220 · 2021: $211 · 2022: $386 · 2024: $20.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,620.73 | 2019 | |
| Gynesonics, INC. | $260.16 | 2022 | |
| Hologic Sales and Service, LLC | $154.69 | 2019-2021 | |
| Abbvie INC. | $134.47 | 2019-2022 | |
| Coopersurgical, INC. | $80.09 | 2019-2021 | |
| Channel Medsystems, INC. | $75.82 | 2021-2022 | |
| Aspira Women'S Health INC | $51.94 | 2021 | |
| Roche Diagnostics Corporation | $42.21 | 2019 | |
| Daiichi Sankyo INC. | $41.43 | 2019-2022 | |
| Minerva Surgical, INC | $39.62 | 2019 | |
| Ethicon US, LLC | $38.25 | 2020-2022 | |
| Boston Scientific Corporation | $34.48 | 2019-2024 | |
| Mylan Pharmaceuticals INC. | $25.11 | 2020 | |
| Alydia Health | $20.71 | 2021 | |
| Amag Pharmaceuticals, INC. | $19.93 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $19.07 | 2022 | |
| Therapeuticsmd, INC. | $14.04 | 2021 | |
| Cook Medical LLC | $11.71 | 2019 | |
| Lupin INC. | $11.43 | 2020 | |
| Organon LLC | $7.67 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grayson Guzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.